Cargando…

A Review of Demographic, Medical, and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood

Hematopoietic stem cell transplantation (HSCT) is a standard treatment after disease relapse and failure of conventional treatments for cancer in childhood or as a first line treatment for some high-risk cancers. Since hematopoietic stem cells can be found in the marrow (previously called a bone mar...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinfjell, Trude, Tremolada, Marta, Zeltzer, Lonnie K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344915/
https://www.ncbi.nlm.nih.gov/pubmed/28344563
http://dx.doi.org/10.3389/fpsyg.2017.00253
_version_ 1782513611949735936
author Reinfjell, Trude
Tremolada, Marta
Zeltzer, Lonnie K.
author_facet Reinfjell, Trude
Tremolada, Marta
Zeltzer, Lonnie K.
author_sort Reinfjell, Trude
collection PubMed
description Hematopoietic stem cell transplantation (HSCT) is a standard treatment after disease relapse and failure of conventional treatments for cancer in childhood or as a first line treatment for some high-risk cancers. Since hematopoietic stem cells can be found in the marrow (previously called a bone marrow transplantation) or periphery, we refer to HSCT as inclusive of HSCT regardless of the origin of the stem cells. HSCT is associated with adverse side effects, prolonged hospitalization, and isolation. Previous studies have shown that survivors of HSCT are at particularly high risk for developing late effects and medical complications, and thus, in addition to survival, quality of life in survivors of HSCT is an important outcome. This review summarizes and distills findings on the health-related quality of life (HRQOL) of long-term childhood cancer survivors of HSCT and examines significant sociodemographic, medical, disease and treatment correlates of HRQOL, as well as the methodology of the studies (instruments, type of studies, timing of assessment, type of transplantation). Because previous reviews covered the studies published before 2006, this review searched three databases published between January, 2006, and August, 2016. The search identified nine studies, including 2 prospective cohort studies and 7 cross-sectional studies. All studies reported a follow-up time of >5 years. The review found that HRQOL is significantly impacted over time following childhood HSCT, with salient correlates of HRQOL found to be presence of a severe chronic health or major medical condition, graft vs. host disease (GVHD), or pain. Continual evaluation of HRQOL must be integrated into long-term follow-up after childhood HSCT, and intervention should be offered for those survivors with poor HRQOL. Longitudinal studies should be emphasized in future research to allow for predictor models of resilience and poor HRQOL.
format Online
Article
Text
id pubmed-5344915
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53449152017-03-24 A Review of Demographic, Medical, and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood Reinfjell, Trude Tremolada, Marta Zeltzer, Lonnie K. Front Psychol Psychology Hematopoietic stem cell transplantation (HSCT) is a standard treatment after disease relapse and failure of conventional treatments for cancer in childhood or as a first line treatment for some high-risk cancers. Since hematopoietic stem cells can be found in the marrow (previously called a bone marrow transplantation) or periphery, we refer to HSCT as inclusive of HSCT regardless of the origin of the stem cells. HSCT is associated with adverse side effects, prolonged hospitalization, and isolation. Previous studies have shown that survivors of HSCT are at particularly high risk for developing late effects and medical complications, and thus, in addition to survival, quality of life in survivors of HSCT is an important outcome. This review summarizes and distills findings on the health-related quality of life (HRQOL) of long-term childhood cancer survivors of HSCT and examines significant sociodemographic, medical, disease and treatment correlates of HRQOL, as well as the methodology of the studies (instruments, type of studies, timing of assessment, type of transplantation). Because previous reviews covered the studies published before 2006, this review searched three databases published between January, 2006, and August, 2016. The search identified nine studies, including 2 prospective cohort studies and 7 cross-sectional studies. All studies reported a follow-up time of >5 years. The review found that HRQOL is significantly impacted over time following childhood HSCT, with salient correlates of HRQOL found to be presence of a severe chronic health or major medical condition, graft vs. host disease (GVHD), or pain. Continual evaluation of HRQOL must be integrated into long-term follow-up after childhood HSCT, and intervention should be offered for those survivors with poor HRQOL. Longitudinal studies should be emphasized in future research to allow for predictor models of resilience and poor HRQOL. Frontiers Media S.A. 2017-03-10 /pmc/articles/PMC5344915/ /pubmed/28344563 http://dx.doi.org/10.3389/fpsyg.2017.00253 Text en Copyright © 2017 Reinfjell, Tremolada and Zeltzer. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychology
Reinfjell, Trude
Tremolada, Marta
Zeltzer, Lonnie K.
A Review of Demographic, Medical, and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood
title A Review of Demographic, Medical, and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood
title_full A Review of Demographic, Medical, and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood
title_fullStr A Review of Demographic, Medical, and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood
title_full_unstemmed A Review of Demographic, Medical, and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood
title_short A Review of Demographic, Medical, and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood
title_sort review of demographic, medical, and treatment variables associated with health-related quality of life (hrqol) in survivors of hematopoietic stem cell (hsct) and bone marrow transplantation (bmt) during childhood
topic Psychology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344915/
https://www.ncbi.nlm.nih.gov/pubmed/28344563
http://dx.doi.org/10.3389/fpsyg.2017.00253
work_keys_str_mv AT reinfjelltrude areviewofdemographicmedicalandtreatmentvariablesassociatedwithhealthrelatedqualityoflifehrqolinsurvivorsofhematopoieticstemcellhsctandbonemarrowtransplantationbmtduringchildhood
AT tremoladamarta areviewofdemographicmedicalandtreatmentvariablesassociatedwithhealthrelatedqualityoflifehrqolinsurvivorsofhematopoieticstemcellhsctandbonemarrowtransplantationbmtduringchildhood
AT zeltzerlonniek areviewofdemographicmedicalandtreatmentvariablesassociatedwithhealthrelatedqualityoflifehrqolinsurvivorsofhematopoieticstemcellhsctandbonemarrowtransplantationbmtduringchildhood
AT reinfjelltrude reviewofdemographicmedicalandtreatmentvariablesassociatedwithhealthrelatedqualityoflifehrqolinsurvivorsofhematopoieticstemcellhsctandbonemarrowtransplantationbmtduringchildhood
AT tremoladamarta reviewofdemographicmedicalandtreatmentvariablesassociatedwithhealthrelatedqualityoflifehrqolinsurvivorsofhematopoieticstemcellhsctandbonemarrowtransplantationbmtduringchildhood
AT zeltzerlonniek reviewofdemographicmedicalandtreatmentvariablesassociatedwithhealthrelatedqualityoflifehrqolinsurvivorsofhematopoieticstemcellhsctandbonemarrowtransplantationbmtduringchildhood